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Abstract
Rotaviruses are the most important etiological agent of acute gastroenteritis in young children worldwide. Among the first countries
to introduce rotavirus vaccines into their national immunization programs were Belgium (November 2006) and Australia (July 2007).
Surveillance programs in Belgium (since 1999) and Australia (since 1989) offer the opportunity to perform a detailed comparison of
rotavirus strains circulating pre- and postvaccine introduction. G1P[8] rotaviruses are the most prominent genotype in humans, and a
total of 157 G1P[8] rotaviruses isolated between 1999 and 2011 were selected from Belgium and Australia and their complete
genomes were sequenced. Phylogenetic analysis showed evidence of frequent reassortment among Belgian and Australian G1P[8]
rotaviruses. Although many different phylogenetic subclusters were present before and after vaccine introduction, some unique
clusters were only identified after vaccine introduction, which could be due to natural fluctuation or the first signs of vaccine-driven
evolution. The times to the most recent common ancestors for the Belgian and Australian G1P[8] rotaviruses ranged from 1846 to
1955 depending on the gene segment, with VP7 and NSP4 resulting in the most recent estimates. We found no evidence that
rotavirus population size was affected after vaccine introduction and only six amino acid sites in VP2, VP3, VP7, and NSP1 were
identified to be under positive selective pressure. Continued surveillance ofG1P[8] strains is needed to determine long-term effects of
vaccine introductions, particularly now rotavirus vaccines are implemented in the national immunization programs of an increasing
number of countries worldwide.
Key words: rotavirus, G1P[8], vaccine introduction, phylodynamics.
Introduction
Rotavirus is the most common viral cause of acute gastroen-
teritis in infants and young children worldwide. Rotavirus infec-
tion results in 114 million episodes of gastroenteritis, 24 million
clinic visits, and 2.4 million hospitalizations annually (Glass et al.
2006). Of the estimated 453,000 annual deaths, the majority
occur in developing nations in Asia and sub-Saharan Africa
(Tate et al. 2012). Rotavirus belongs to the Reoviridae virus
family and has a double-stranded RNA genome composed of
11 gene segments. The genome encodes six structural viral
proteins (VP14, VP6, VP7) and six nonstructural proteins
(NSP15/6) (Estes and Greenberg 2013). Numerous mecha-
nisms impact the dynamics of rotavirus diversity including ge-
netic shift, genetic drift, recombination, and zoonotic
transmission. The accumulation of spontaneous sequential
point mutations (genetic drift) occurs due to the error-prone
GBE
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nature of the rotavirus RNA-dependent RNA polymerase (Estes
and Greenberg 2013). The rate of mutations has been calcu-
lated for several VP7 genotypes, and a small number of other
genes including VP4 and NSP2, resulting in the identification of
varying mutation rates that may reflect the different selective
pressures exerted on different genes and genotypes (Jenkins
et al. 2002; Matthijnssens, Heylen, et al. 2010; Donker and
Kirkwood 2012; Nagaoka et al. 2012; Trang et al. 2012).
Rotaviruses are classified into eight groups or species
(AH), with group A rotavirus strains being the most
common cause of disease in humans (Matthijnssens et al.
2012). A full genome genotyping classification system for
group A rotaviruses based on the open reading frame (ORF)
of each gene has been established: Gx-P[x]-Ix-Rx-Cx-Mx-Ax-
Nx-Tx-Ex-Hx (Matthijnssens et al. 2011). To date, 27 G (VP7),
37 P (VP4), 17 I (VP6), 9 R (VP1), 9 C (VP2), 8 M (VP3), 18 A
(NSP1), 10 N (NSP2), 12 T (NSP3), 15 E (NSP4), and 11 H
(NSP5) genotypes have been described (Matthijnssens et al.
2011; Guo et al. 2012; Papp et al. 2012; Trojnar et al. 2013;
Jere et al. 2014). This extends the classic classification system
based on the two outer capsid proteins into G (glycoprotein,
VP7) and P (protease sensitive, VP4) genotypes, respectively
(Estes and Greenberg 2013). G1P[8] is the dominant genotype
in countries across the globe and typically exhibits the arche-
typal constellation G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1)
(Santos and Hoshino 2005; Matthijnssens and Van Ranst
2012). In the prevaccine period, surveillance data from
Belgium and Australia indicated that G1P[8] was the dominant
genotype. However, rotavirus genotype distributions fluctu-
ated both geographically and temporally in the absence of
vaccination (Kirkwood 2010; Zeller et al. 2010).
Two live-oral vaccines are currently available on the global
market, Rotarix (GlaxoSmithKline Vaccines, Belgium) and
RotaTeq (Merck and Co., USA), and included in the routine
vaccination programs of many countries including the United
States, Brazil, Belgium, and Australia (Dennehy 2012).
RotaTeq is a live-attenuated pentavalent vaccine that contains
five genetically distinct human–bovine reassortant virus
strains. Each reassortant strain contains a human rotavirus
gene encoding one of the outer capsid proteins (VP7 encoding
G1, G2, G3, or G4; or VP4 encoding P[8]) within a bovine
WC3 strain backbone (G6P[5]) (Heaton et al. 2005;
Matthijnssens, Joelsson, et al. 2010). RotaTeq is administered
in a three dose schedule at 2, 4, and 6 months of age. Rotarix
is a live-attenuated monovalent vaccine composed of a G1P[8]
strain that is administered in a two dose schedule at 2 and 4
months of age (Vesikari et al. 2007).
In early 2006, Rotarix and RotaTeq became commercially
available in Australia and were subsequently introduced into
the Australian National Immunisation Program in July 2007.
Each state and territory independently selected which vaccine
to implement; Victoria, Queensland, Western Australia, and
South Australia used RotaTeq, while New South Wales, the
Northern Territory, Tasmania, and the Australian Capital
Territory used Rotarix (Buttery et al. 2011). By December
2008, the estimated national vaccine coverage was 87% for
at least one dose of vaccine received by 4 months of age, and
84% for a full vaccine course (either two or three doses) by 13
months of age (Macartney and Burgess 2009). Belgium was
the first country in the European Union to introduce rotavirus
vaccines into the routine childhood immunization schedule
with Rotarix and RotaTeq introduced in November 2006 and
June 2007, respectively (Braeckman et al. 2011). Vaccine
coverage reached approximately 90% by the start of the
2007–2008 rotavirus season and the most frequently used
vaccine in Belgium is Rotarix (Zeller et al. 2010; Braeckman
et al. 2011). Several studies have shown that vaccine intro-
duction has significantly decreased the burden of rotavirus
disease in Australia and Belgium (Lambert et al. 2009; Zeller
et al. 2010; Braeckman et al. 2011; Buttery et al. 2011). It is
predicted that vaccine introduction will result in an increase in
selective pressure exerted on wild-type rotavirus strains in the
population, affecting the evolution of these strains.
The aim of this study was to genetically characterize circu-
lating G1P[8] strains in Belgium (Rotarix) and Melbourne,
Australia (RotaTeq), and to investigate viral evolution in the
pre- and postvaccine era.
Materials and Methods
Sample Preparation
Stool samples were collected from children hospitalized under
the age of five as part of the ongoing rotavirus surveillance
studies in Belgium and Australia. Belgian samples were col-
lected from the Gasthuisberg University Hospital, Leuven, and
from other hospitals in Belgium between 1999 and 2010, and
G1P[8] rotaviruses were selected based on the phylogenetic
diversity of VP7 and availability of stool sample. Australian
stool samples were collected from the Royal Children’s
Hospital, Melbourne, Australia, between 2001 and 2011
and were randomly selected based on the availability of
stool samples and the proportion of G1P[8] samples collected
in a given year. No Group A rotavirus strains were included
that were completely or partially vaccine derived.
For each stool sample, RNA extractions were performed
using the QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany) and these were sent to the J. Craig Venter
Institute (Rockville, MD) for sequencing as previously described
(McDonald et al. 2009, 2012). The sequences generated in
this study were deposited in GenBank under the accession
numbers listed in supplementary table S1, Supplementary
Material online.
Bayesian Evolutionary Inference and Phylogenetic
Network Analysis
We estimated time-measured evolutionary histories for each
rotavirus segment using Bayesian phylogenetic inference as
Zeller et al. GBE
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implemented in BEAST (Drummond et al. 2012). The nucleo-
tide substitution process was modeled by separately partition-
ing the codon positions into 1st + 2nd and 3rd positions
(Shapiro et al. 2006) and applying a separate general time-
reversible substitution model with gamma-distributed rate
heterogeneity and a proportion of invariant sites
(GTR + I + gamma) (Tavare´ 1986), under an uncorrelated log-
normal relaxed molecular clock to account for variation in
rates of evolution among lineages (Drummond et al. 2006).
We specified a Bayesian Skygrid coalescent tree prior that
allows the population size to be estimated through time
from a single or multiple unlinked genetic loci (Gill et al. 2013).
Three independent Markov chain Monte Carlo chains were
run for 100 million steps and sampled every 10,000th gener-
ation, with 10% of the generations discarded as chain burn-in.
All analyses were performed using the BEAGLE library to en-
hance computation speed (Suchard and Rambaut 2009; Ayres
et al. 2012). Convergence and mixing of the chains were in-
spected using Tracer version 1.5; all continuous parameters
yielded effective sample sizes greater than 200. A maximum
clade credibility tree was summarized using TreeAnnotator ver-
sion 1.7.4 (Drummond and Rambaut 2007). In addition, a phy-
logenetic network was constructed of all 11 concatenated
ORFs using the SplitsTree4 program (Huson and Bryant
2006). Based on the phylogenetic network, clusters were de-
fined and associations among clusters, country of isolation,
and period of sample collection (before or after vaccine intro-
duction) were determined using Fisher’s exact test.
Selection Pressure Analysis
To estimate site-specific nonsynonymous/synonymous substi-
tution rate ratios (dN/dS), we used the Renaissance counting
methodology that combines estimates of the number of
synonymous and nonsynonymous substitutions at each site
with an empirical Bayes procedure to produce a posterior dis-
tribution of dN/dS ratios for all sites in the alignment (Lemey
et al. 2012). In addition, dN/dS ratios were also computed using
the Mixed Effects Model of Evolution (MEME), Single likelihood
ancestor counting (SLAC), Fixed Effects Likelihood (FEL), and
Fast Unconstrained Bayesian AppRoximation (FUBAR) algo-
rithms as implemented in the Datamonkey webserver (Pond
et al. 2005; Delport et al. 2010). As outcomes can differ con-
siderably depending on the chosen method, we only consid-
ered sites that were under positive selection pressure according
to three or more of the five abovementioned methods.
Results
The complete ORF of all 11 gene segments of 69 and 88
G1P[8] rotaviruses from Belgium and Australia, respectively,
isolated before and after vaccine introduction were deter-
mined. In total, 78 G1P[8] strains were detected before vac-
cine introduction and 79 strains were detected after vaccine
introduction. The majority of the Australian samples were col-
lected after 2004, whereas Belgian samples were collected
from 1999 until 2010 although no samples were collected
in 2004 (fig. 1).
The level of reassortment in the ancestral history of the
Belgian and Australian G1P[8] rotaviruses was investigated
by constructing a phylogenetic network from concatenated
sequences of the 11 genes (fig. 2A). The phylogenetic net-
work showed that the G1P[8] strains were distributed among
three main clusters, each containing multiple subclusters. The
presence of a large number of incompatible splits in the net-
work indicates the occurrence of frequent reassortment
events between strains belonging to the same or different
clusters. Belgian and Australian G1P[8] strains were found in
FIG. 1.—Sampling distribution of G1P[8] rotaviruses used in this study. Australian G1P[8] strains are indicated in blue, whereas Belgian G1P[8] strains are
indicated in orange. For each year, the number of selected strains is shown.
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FIG. 2.—Phylogenetic network of 69 Belgian and 88 Australian concatenated G1P[8] strains. Branches are drawn to scale and splits in the network
indicate reassortments. Clusters are color coded according to the legend by country (A) or by isolation before or after vaccine introduction (B).
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each of the three clusters, although only six Australian strains
were observed in cluster 2. Within every cluster, separate sub-
clusters could be identified containing only strains from either
Belgium or Australia. However, several subclusters (shaded
green in fig. 2B), predominately in cluster 2 and 3, contained
both Belgian and Australian strains reflecting rapid global dis-
semination of G1P[8] rotaviruses. No overall association was
observed between the country of isolation and the period of
sampling (pre- or postvaccine introduction) (table 1). Focusing
on specific clusters, the country of isolation and the period of
sampling were not significantly related to each other for clus-
ter 2 and 3 (P= 0.37 and P= 0.33, respectively). For cluster 1,
however, less strains were isolated in Belgium after rotavirus
vaccine introduction (P= 0.01).
Each of the three main clusters and the majority of the
subclusters contained closely related G1P[8] strains from
both Belgium and Australia collected before and after rotavi-
rus vaccine introduction (fig. 2B). Subclusters were identified
that contain unique strains detected before (shaded green) or
after vaccine introduction (shaded red), although in most
cases these clusters also coincided with a single sampling lo-
cation and period (fig. 2B). The majority of subclusters con-
taining only strains identified after vaccine introduction were
observed in cluster 3, and generally represented unique strains
in either Belgium or Australia.
To further investigate the evolutionary dynamics for the
individual gene segments, we constructed phylogenetic
trees for all 11 gene segments using the Bayesian phylogenetic
inference of time-measures trees as implemented in the
BEAST package. The VP7 and VP4 genes were segregated in
two and three lineages, respectively (fig. 3). For VP7, both
lineages were approximately of equal size and contained
Belgian and Australian strains. Belgian and Australian strains
were more intermingled in lineage 2, while separate clusters
of Belgian or Australian strains were more frequently observed
in lineage 1, indicating more localized epidemics in each coun-
try (fig. 3A). For VP4, three lineages were observed, but the
majority of the strains were found in lineage 1. Belgian and
Australian G1P[8] strains were more intermingled within line-
age 1 compared with lineage 2 or 3. Most strains that formed
closely related clusters for VP7 were also closely related for
VP4, although some of these clusters show evidence of reas-
sortment as there is no complete congruency between VP7
and VP4 lineages. Within lineage 1 and 2 several clades con-
taining Australian G1P[8] strains were detected. One Belgian
strain was distinct from all other P[8] VP4 genes characterized
in this study. It clustered separately from all other Belgian and
Australian G1P[8] strains and was most closely related to
OP354-like P[8] VP4 genes (data not shown).
The phylogenetic trees of the other nine gene segments of
Belgian and Australian G1P[8] strains also revealed the occur-
rence of two or more lineages for each gene segment (sup-
plementary fig. S1, Supplementary Material online). Four gene
segments possessed only two lineages (VP1, VP3, NSP1, and
NSP5), while VP6, NSP3, and NSP4 possessed a third lineage
comprising one or two Australian (VP6 and NSP3) or Belgian
(NSP4) G1P[8] strains. The phylogenetic trees of NSP2 and VP2
revealed four and five lineages, respectively. In general,
Belgian and Australian G1P[8] strains were present in all
major lineages for all these gene segments, although localized
clusters of closely related strains were more prominently pre-
sent for the Australian strains compared with the Belgian
G1P[8] strains (supplementary fig. S1, Supplementary
Material online).
We also investigated the clustering patterns of Belgian and
Australian G1P[8] strains with respect to their time of isolation
(before or after vaccine introduction). For VP7 and VP4,
G1P[8] strains isolated before and after vaccine introduction
were present in the two major lineages (fig. 3B). However, for
VP7, 60% (45 of 75) of all lineage 2 strains were isolated after
vaccine introduction, whereas for lineage 1 only 44% (36 of
82) of the strains were isolated after vaccine introduction
(P= 0.06) (fig. 2). For VP4, strains isolated before and after
vaccine introduction were evenly distributed across the differ-
ent lineages (51%; 24 of 47 and 56 of 109 for lineage 1 and 2,
respectively; P= 1.00) (fig. 3B), but strains isolated after vac-
cine introduction dominated in one particular clade within
lineage 1. For the other nine gene segments, strains isolated
before and after vaccine introduction were also observed in all
major lineages and strains isolated before and after vaccine
introduction were approximately evenly distributed across the
different lineages. Gene segments from G1P[8] strains isolated
before and after vaccine introduction were sometimes also
found to be closely related, indicating a prolonged circulation
of a gene variant for an extended period of time
Table 1
Distribution of Samples Per Cluster, Country of Collection, and Date
of Collection
Number of
Samples Isolated
in the Prevaccine
Introduction
Period (%)
Number of
Samples Isolated
in the Postvaccine
Introduction
Period (%)
Total
Overall
Australia 42 (52.3) 46 (47.7) 88
Belgium 36 (47.8) 33 (52.2) 69
Total 79 (50.3) 78 (49.7) 157
Cluster I
Australia 15 (41.7) 21 (58.3) 36
Belgium 13 (81.3) 3 (18.8) 16
Cluster 2
Australia 1 (16.7) 5 (83.3) 6
Belgium 12 (42.9) 16 (57.1) 28
Cluster 3
Australia 26 (56.5) 20 (43.5) 46
Belgium 11 (44.0) 14 (56.0) 25
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(supplementary fig. S2, Supplementary Material online). There
were sublineages present in numerous trees, such as NSP1,
NSP3, and NSP4, that predominantly or exclusively comprised
strains collected during the postvaccine era.
Using the combined data set of all Belgian and Australian
G1P[8] rotaviruses, we calculated the time to the most recent
common ancestor (TMRCA) for all 11 gene segments. The
TMRCAs ranged from 1846 to 1955 (fig. 4A). The youngest
TMRCAs were observed for VP7 (1955; 95% highest posterior
density [HPD]: 1932–1975) and NSP4 (1954; 95% HPD:
1938–1971). Other gene segments with relatively young
TMRCAs were VP1, VP2, VP3, NSP3, and NSP5. Remarkably
older TMRCAs were observed for the VP4, VP6, NSP1, and
NSP2 gene segments. For VP4, this was partially the result of a
201020001990198019701960195019051800
VP7
VP4
Time (years)
201020001990198019701960195019051800
Time (years)
VP7
VP4
A B
Lineage 2
Lineage 1
Lineage 1
Lineage 2
Lineage 3
Lineage 1
Lineage 2
Lineage 3
Lineage 2
Lineage 1
FIG. 3.—Bayesian maximum clade credibility tree based on the nucleotide sequence of 157 VP7 and VP4 gene segments. The color coding of the
branches is based on the country of origin (orange for Belgium and blue for Australia) (A). The color coding is based on the year of isolation (green for strains
isolated before rotavirus vaccine introduction and red for strains isolated after rotavirus vaccine introduction) (B).
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single outlier strain in lineage 3 (the TMRCA of P[8] lineage 1
and P[8] lineage 2 strains was estimated at 1889; 95% HPD:
1832–1942), while for VP6, NSP1, and NSP2 a comparatively
large genetic diversity resulted in a relatively old TMRCA
(fig. 4A). A separate TMRCA analysis was conducted for the
data sets from each country resulting in similar findings,
except for VP4, NSP1, and NSP5. For these gene segments,
the TMRCA of Australian strains was more recent than those
of Belgian strains, due to a lower genetic diversity in the strains
isolated in Australia (data not shown). We also calculated the
evolutionary rate for each gene segment, which revealed only
marginal differences between the different gene segments
(fig. 4B). The evolutionary rates for each gene segment
ranged from 6.05104 to 1.01 103. The highest muta-
tion rates were observed for NSP1 (1.01 103; 95% HPD:
8.44104 to 1.18103) and NSP4 (1.01103; 95%
HPD: 7.39104 to 1.33103), respectively.
The population size estimates through time for the Belgian
and Australian VP7, VP4, VP6, and NSP4 genes showed a
relative stable profile with a few peaks and troughs during
the sampling period (1999–2011) (fig. 4C). Comparison with
the Skygrid plots of other gene segments also revealed similar
patterns. There is one exception, NSP1, were the peaks and
troughs were absent and the Skygrid plot is completely flat.
However, as the peaks and troughs were found in almost all
other gene segments and were observed well before the
introduction of rotavirus vaccines, they were more likely the
result of sampling biases rather than vaccine introduction
(supplementary fig. S3, Supplementary Material online).
Each gene segment was tested for sites under positive
selection using a Belgian data set, an Australian data set,
and the combined data set. Sites under positive selection
were identified in VP2 (aa 40, 42), VP3 (aa 326, 683), VP7
(aa 28), and NSP1 (aa 422) by at least three of the five used
models (table 2). No sites under positive selection were iden-
tified in the other seven rotavirus gene segments.
Nonconservative amino acid variation was identified at the
majority of sites under positive selection. However, amino
acid variation at sites under positive selection did not differen-
tiate before and after vaccine introduction in G1P[8] strains
identified in either Belgian or Australian strains.
Discussion
In this study, we investigated the impact of rotavirus vaccine
introduction on the most common human rotavirus genotype
G1P[8]. To our knowledge, this is the first large-scale genomic
analysis of human rotaviruses collected before and after rota-
virus vaccine introduction. Australia and Belgium were among
the first countries worldwide where rotavirus vaccines were
implemented in national immunization programs. In Belgium,
the most commonly used vaccine is Rotarix, while in Australia
different states are using different rotavirus vaccines (Zeller
et al. 2010; Buttery et al. 2011). The samples in this study
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were collected from Victoria where RotaTeq is the only vaccine
used (Buttery et al. 2011). Vaccination coverage was high in
both countries, which provides a unique opportunity to inves-
tigate the early effect of vaccine introduction on the genetic
diversity of G1P[8] rotaviruses (Braeckman et al. 2014; Hull
et al. 2014). Three different clusters could be identified in
the phylogenetic network that was constructed using
sequences derived from the concatenation of the 11 rotavirus
genes (fig. 2). Of particular interest is cluster 1, which is
predominantly composed of Belgian G1P[8] strains from the
prevaccine era. In Australia, no difference was found in the
prevalence of G1P[8] strains in cluster 1 before and after vac-
cine introduction, which could possibly be the result of the
different vaccines used in the national immunization programs
of both countries. On the contrary, Australian G1P[8] strains
belonging to cluster 2 were found more frequently after vac-
cine introduction, although this difference was not statistically
significant as only 6.8% of all Australian G1P[8] strains were
found in cluster 2. Lineage replacement has been suggested
as an important evolutionary mechanism for rotaviruses to
adapt to different immunological environments (McDonald
et al. 2009; Zeller et al. 2012; Dennis et al. 2014; Zhang
et al. 2014; Magagula et al. 2015) and the observed changes
in lineage frequency could be an adaptation of the rotavirus
population to evade immunological pressures of widespread
vaccine use. However, when interpreting these data the dif-
ferent sample selection methods in Belgium and Australia
should be kept in mind. In Belgium, samples were selected
based on genetic diversity of VP7, whereas in Australia a
random sample collection occurred. This may, for example,
explain why Australian G1P[8] strains more frequently
formed closely related subclusters in many gene segments
as compared with Belgian strains.
For every gene segment at least two lineages were present
within the Australian and Belgian G1P[8] strains, this is similar
to that observed in the few other large-scale genomics studies
investigating Wa-like rotaviruses (McDonald et al. 2009,
2012; Roy et al. 2014; Zhang et al. 2014; da Silva et al.
2015). No data are currently available about rotavirus vaccine
effectiveness against intragenotypic lineages, but it seems un-
likely that the difference in vaccine effectiveness is larger be-
tween different intragenotypic lineages than between
different genotypes. Vaccine efficacy against rotavirus diar-
rhea of any severity for different rotavirus genotypes has
been well studied and ranges between 61% and 88% for
Rotarix and 88% and 95% for RotaTeq depending on the
genotype (Soares-Weiser et al. 2012). In a Belgian case–con-
trol study, the vaccine effectiveness of Rotarix against the
most common human genotypes ranged from 85% to
95% with only small differences between the vaccine effec-
tiveness against Wa-like genotype strains G1, G3, and G4
(Braeckman et al. 2012; Matthijnssens et al. 2014). The dif-
ferences in vaccine effectiveness between different lineages
of G1P[8] strains are expected to be low. This was also
suggested by our findings as only subtle differences were
detected in the genetic diversity of the different rotavirus
gene segments before and after vaccine introduction. For ex-
ample, the majority of strains clustering in VP7 lineage 2 were
isolated after vaccine introduction, whereas for VP7 lineage 1
most strains were isolated before vaccine introduction.
Despite changes in genetic diversity, the rotavirus population
size remained stable throughout the sampling period. As only
relatively few countries were using rotavirus vaccines between
2006 and 2010, a potential effect on the rotavirus population
size in Belgium and Australia could have been diluted by
rotavirus strains migrating from other countries without a
universal rotavirus vaccination program.
Belgium and Australia are located on the northern and
southern hemisphere, respectively, and therefore experience
rotavirus seasons that do not overlap each other. Despite this,
we found Belgian and Australian G1P[8] rotaviruses in subse-
quent rotavirus seasons that were very closely related. It is
unknown whether this is the result of direct transmission be-
tween Belgium and Australia or that both viruses originate
from a third country, for example, in the tropics where rota-
virus infections occur year round (Levy et al. 2009). However,
it is likely that G1P[8] strains detected in Belgian and Australia
are part of a global pool of circulating G1P[8] strains. The
phylogenetic analysis revealed several lineages that circulated
in the pre- and postvaccine era. Several unique genetic clus-
ters, based on whole genome concatenation or specific gene
segments that represented unique subclusters/lineages, were
only present in the postvaccine introduction samples and war-
rant further monitoring. More extensive sampling of larger
genomic data sets collected over a longer time period in
Belgium and Australia as well as samples collected in different
Table 2
Summary of Positive Selection in G1P[8] Genome Segmentsa
Genome
Segment
Site Selection
Model
Amino Acid
Variation
VP2
40 (Belgium +
Australia)
MEME, SLAC, FEL,
FUBAR
R/K/I
42 (Belgium) MEME, FEL, RC Q/H
VP3
326 (Australia) MEME, FEL, RC K/N/E
683 (Belgium) MEME, FEL, RC G/E
VP7
28 (Belgium +
Australia)
MEME, SLAC, FEL R/Q
NSP1
422 (Belgium +
Australia)
MEME, FEL, RC Q/H/K
RC, Renaissance counting.
aOnly sites are considered that are under positive selection according to three
or more out of five models (MEME, SLAC, FEL, FUBAR, or RC).
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locations in the world would help to elucidate global patterns
of rotavirus transmission.
Surprisingly, we found large variations in the TMRCA for dif-
ferent rotavirus gene segments, which could not be attributed
to differences in evolutionary rates among segments (fig. 4).
Especially, for VP4, VP6, NSP1, and NSP2 the TMRCAs were
approximately 100 years older than those of many other gene
segments and displayed a large genetic diversity (fig. 4 and
supplementary fig. S1, Supplementary Material online). In
contrast, the VP7 and NSP4 gene segment histories have a
relatively recent TMRCA. Human rotaviruses are subdivided
into Wa-like and DS-1-like genotype constellations. For most
gene segments generally only two genotypes (1 or 2) are
frequently present in human rotaviruses, while for VP7 six
genotypes are regularly found: G1–G4, G9, and G12
(Matthijnssens and Van Ranst 2012). The conserved Wa-like
genetic backbone allows for frequent reassortment and circu-
lates in combination with varying G genotypes. Therefore,
each G genotype is more limited in circulation compared
with genotypes of other genes, which results in a decreased
ability of G1 genotypes to accumulate mutations. For this
study, only rotaviruses bearing the G1 genotype were selected
and a large part of VP7 genetic diversity was thus omitted a
priori. The TMRCA for the NSP4 segment was estimated at
1954, which together with a high mutation rate and limited
genetic diversity suggest that the NSP4 E1 genotypes may
have gone through a genetic bottleneck. The wide array of
functions that have been assigned to the NSP4 protein, in
particular the interaction with other VPs and its function as
an enterotoxin (Hu et al. 2012), probably exercises a strong
purifying selection pressure.
Selection pressure analysis of Australian and Belgian G1P[8]
rotavirus strains identified several sites under positive selection
in VP2, VP3, VP7, and NSP1, several of which were found in
regions containing known cytotoxic T lymphocyte epitopes
(VP2, VP3, and VP7), or protein domains that interact with
innate immune factors (NSP1) (Franco et al. 1993, 1994;
Buesa et al. 1999; Newell et al. 2013). The site under positive
selection in NSP1 (aa 422) is located in the highly variable
C-terminal region, involved in downregulation of the innate
immune response by binding interferon-regulatory factors
(IRF3, IRF5, and IRF7) and inhibiting NFkB through degradation
of b-TrCP (Barro and Patton 2005; Arnold and Patton 2011).
These data suggest that sequence variation at sites under pos-
itive selection in multiple VPs may be involved in immune
escape of circulating G1P[8] strains. However, given the
extent of genetic diversity between different G1P[8] lineages,
a change in G1P[8] lineage frequency is likely to be a more
dominant evolutionary mechanism to respond to selection
pressures such as the introduction of rotavirus vaccines.
To conclude, we found limited differences between the
Belgian and Australian G1P[8] rotaviruses, even though differ-
ent vaccines were used in both locations. Despite the fact that
rotavirus vaccine introduction has decreased rotavirus
hospitalizations in many countries, our data suggest that ro-
tavirus vaccination may impact the evolution of G1P[8] rota-
viruses even though one of the vaccines, Rotarix, consists of a
G1P[8] rotavirus strain. However, in this study, we only looked
at limited rotavirus seasons after vaccine introduction in a
period where only a small number of countries had imple-
mented universal rotavirus vaccination programs, and as still
little is known about the long-term evolution of rotaviruses,
we cannot rule out that our results are limited by this.
Therefore, an extended surveillance of G1P[8] rotaviruses
would be valuable to ascertain long-term effects of vaccine
introduction.
Supplementary Material
Supplementary figures S1–S3 and table S1 are available at
Genome Biology and Evolution online (http://www.gbe.
oxfordjournals.org/).
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